DXCM vs ZBH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DXCM Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DexCom, Inc. (DXCM) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ZBH counters with relative strength in Valuation. Fundamentally, DXCM trades at 25.3x Forward P/E with 24.0% operating margin (+11.2% YoY revenue) versus ZBH at 11.3x Forward P/E and 16.7% operating margin (+3.1% YoY). In options structure, DXCM sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against ZBH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DXCM Revenue | ZBH Revenue | DXCM Op. Margin | ZBH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $1.03B | $7.93B | -18.1% | 0.4% | ZBH |
| FY2019 | $1.48B | $7.98B | 9.6% | 14.3% | ZBH |
| FY2020 | $1.93B | $6.13B | 15.5% | 1.4% | DXCM |
| FY2021 | $2.45B | $6.83B | 10.9% | 12.6% | ZBH |
| FY2022 | $2.91B | $6.94B | 13.4% | 10.0% | DXCM |
| FY2023 | $3.62B | $7.39B | 16.5% | 17.3% | ZBH |
| FY2024 | $4.03B | $7.68B | 14.9% | 16.7% | ZBH |
| FY2025 | $4.66B | $8.23B | 19.6% | 13.3% | DXCM |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DXCM | ZBH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9B | $19.2B | Larger Scale | DXCM |
| Trailing P/E Ratio Valuation | 31.6x | 25.6x | Lower Multiple | ZBH |
| Forward P/E Ratio Valuation | 25.3x | 11.3x | Lower Multiple | ZBH |
| Revenue Growth (YoY) Growth | +11.2% | +3.1% | Higher Growth | DXCM |
| Operating Margin (TTM) Profitability | 24.0% | 16.7% | Higher Margin | DXCM |
| Net Profit Margin Profitability | 19.4% | 8.9% | Higher Margin | DXCM |
| Return on Equity (ROE) Capital Efficiency | 37.7% | 6.0% | Higher ROE | DXCM |
| 52-Week Range Position Momentum | 63% ($57โ$93) | 66% ($79โ$113) | Stronger Trend | ZBH |
| Beta / 30D Volatility Risk Regime | 0.59ฮฒ ยท 43% Vol | 0.40ฮฒ ยท 54% Vol | Lower Realized Risk | DXCM |
| Unified Institutional Score Composite Signal | 50.8 / 100 (HOLD) | 46.6 / 100 (HOLD) | Higher Composite | DXCM |